Articles by Paul Breaux
Practice Home Page
HIPAA Privacy Rule—What should you be doing now...? Assessing
January 5, 2001© Paul J. Breaux completed Pharmacy School in 1965. After practicing pharmacy for several years, he entered L.S.U. Law School, graduating in 1972, and he has practiced law since then. His practice is located in Lafayette, Louisiana.
Now that the health care privacy standards mandated by the Administrative Simplification provisions of HIPAA 1996 are promulgated as a final federal rule, pharmacies should begin the process of assessing their respective situations. The following are some areas for Louisiana pharmacies that should be reviewed in preparation for HIPAA Privacy Rule compliance.
  1. DETERMINE IF LOUISIANA HAS STATUTES OR REGULATIONS RELATED TO PRIVACY OF PATIENT HEALTH INFORMATION.
  2. As an example, do patients have a right to access, inspect, and copy their medical records? What types of "uses and disclosures" (in "HIPAAese") in your practice require under Louisiana law a patient consent or authorization (e.g., law enforcement, marketing, etc.)? Do patients have the right to amend their medical/prescription records? What are the medical record retention requirements for patients of your pharmacy practice; and, if none for a pharmacy, then all patient medical records generally? This information is needed in order to determine if Louisiana's statutes and rules will be preempted, or the need to comply eliminated, by the new federal HIPAA Privacy Rule.

  3. DIAGRAM THE TYPICAL FLOW OF PATIENT INFORMATION WITHIN YOUR PHARMACY.
  4. The flow should start at the time of initiation of service (first prescription, first consultation, etc.) and progress through to the conclusion of the patient service process. This flow diagram should be used in conjunction with the inventories of systems and users discussed below.

  5. IDENTIFY ALL OF YOUR PHARMACY'S POLICIES AND PROCEDURES RELATED TO USES, AND DISCLOSURES, OF INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION.
  6. This would enable a pharmacy to determine what may need to be deleted, added or otherwise revised. Likewise, this should raise the awareness within your pharmacy staff that patient privacy, though not a new concept, is governed under a different set of rules — new patient rights and new provider duties.

  7. CREATE AN INVENTORY OF ALL SYSTEMS AND MEDICAL EQUIPMENT THAT CONTAIN, TEMPORARILY OR PERMANENTLY, PATIENT HEALTH/MEDICAL INFORMATION.
  8. Along with each system or piece of equipment (computer in the pharmacy, as one example.), list/show what patient information is customarily stored in it, who has access to the information, what, if any, access controls are in place and what audit trails are available. This inventory will assist in identifying systems that may require some type of remediation, e.g., computer CRT's are to never be left unattended, but if left unattended, then turned off. You may also want to add this information to the flow diagram to assist in identifying electronic versus paper information.

  9. INVENTORY WHICH PERSONS ON YOUR STAFF HAVE ACCESS TO, USE, OR DISCLOSE, INDIVIDUALLY IDENTIFIABLE HEALTH INFORMATION.
  10. It is useful to list the 18 criteria (page 60054 of the Federal Register from the proposed rule; §164.514 of the final rule) when asking this question, because many individuals in your workforce may not realize that they access, use, or disclose what the new federal rule deems to be individually identifiable health information. Once gathered, the individuals should then be added to the flow diagram of patient information.

  11. INVENTORY CURRENT "BUSINESS ASSOCIATES."
  12. Begin to document each contractor, auditor, etc., that has access to, or receives from your pharmacy, patient health information that exists in your pharmacy, including what types of individually identifiable health information they access, use, or disclose, and how frequently they do so.

  13. INVENTORY ROUTINE AND AD HOC REPORT REQUESTS THAT CONTAIN ANY OR ALL OF THE 18 CRITERIA IN THE RULE.
  14. Be certain to include routine downloads (for example, state reporting, patient satisfaction surveying, outcomes reporting, etc.) in this inventory.

  15. INVENTORY WHAT, IF ANY, PATIENT PRIVACY AND CONFIDENTIALITY TRAINING IS BEING OFFERED TO OR RECEIVED BY EMPLOYEES AND CONTRACTORS (BUSINESS ASSOCIATES).
  16. Is this routine training or only offered during the period of new employee orientation, for example? Is there a tracking/documenting of attendance?

  17. CREATE A NOTICE OF PRIVACY PRACTICES.

    Using the information obtained in the foregoing steps, begin the creation of a Notice of Privacy Practices, and increase the awareness and sensitivity among all staff members as to patient health information. There must also be a signed patient consent in conjunction with the Notice of Privacy Practices, and both documents are required by the HIPAA Privacy Rule.


To obtain the above information, your pharmacy, depending on its size, might be able to use an existing committee (e.g., a compliance committee), and if not, then might create such a committee. As each of the above areas is discussed, detailed documentation, minutes, should be maintained. This documentation may then be used to compare against the standards in the federal HIPAA Privacy Rule.

By starting the privacy assessment now, your pharmacy will experience an added value of creating a heightened awareness of the standards, and it will reinforce the significance of the obligation to create and maintain private health information of your patients in confidence, in its staff.

HIPAA Privacy
Overview of HIPAA
Disclosure Authorization
Subpoena of Health Information
Complaints Under the HIPAA Medical Privacy Rule
Notices of Privacy Practices
Incidental Disclosures
HIPAA Requires Pharmacies to have a "Privacy Officer"

Legal Documents,
Policies and Procedures, and Patient Forms

A Start-up Checklist for Your Pharmacy's HIPAA Compliance
What should you be doing now . . . ? Assessing
Privacy, Confidentiality, and Security: of Health Information.
HIPAA Security
Corporations
Pharmacy Law
Personal Planning
Controlled Substances
Business Law
Corporate Compliance
Health Care Fraud

This memorandum analysis is provided as an informational service of Paul J. Breaux, Ltd. It is not intended to
provide specific legal advice or opinion, which may be based only on individual fact situations.
 

phone: 337.266.2270 | Mail: 600 Jefferson Street, Suite 503, Lafayette, LA 70501 |

Articles | Profile | Disclaimer | © 2005 Paul J. Breaux, Ltd.